Drugs / Inactivated Poliomyelitis Vaccine (Sabin strains)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01056705 | Jul 2009 → May 2010 | poliomyelitis | Chinese Academy of Medical Sciences | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01510366 | Jan 2012 → Sep 2015 | poliomyelitis | Institute of Medical Biology, Chinese Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Poliomyelitis Vaccine (Sabin strains) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01510366 ↗ |
| Known as | sIPV | “In a previous phase 3 clinical trial, we showed that an inactivated poliovirus vaccine derived from the Sabin strain (sIPV) can induce neutralising antibodies against currently...” PMID 37745024 ↗ Sep 2023 |
| Modality | Vaccine | “A Sabin strain-based inactivated poliomyelitis vaccine (Sabin-IPV) is the rational option for completely eradicating poliovirus transmission.” PMID 28419204 ↗ May 2017 |
| Route | Intramuscular | “3 x 0.5ml intramuscular injections” NCT01510366 ↗ |